SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.230-1.0%10:04 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich H who wrote (381)10/14/1999 7:40:00 PM
From: Steve Lokness   of 441
 
Interesting question. When SDIX was about 2.00 dollars a share, I made this same suggestion on the Yahoo thread. I felt at the time that it would have made an excellent fit for Neogen if the industrial testing was then resold. It is the industrial testing which has been a drain on the profits of SDIX. Since that time SDIX has been rocketing and I don't know how anyone could ever justify the market cap that shareholders would demand. The opportunity may have been missed if in fact it was ever a possibility.

You previously asked why NEOG did not make more of a deal of comparing this taxed quarters to previously untaxed ones. I suspect the reason was that for some reason the tax rate decreased in the last quarter to a trifling 9%. Wonder were they found the deducts to bring it back down? The mystery of the numbers.

Good Investing!
kivtan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext